Diagnosis and management of uncomplicated chlamydia trachomatis infections in adolescents and adults: Summary of evidence reviewed for the 2010 centers for disease control and prevention sexually transmitted diseases treatment guidelines

Clinical Infectious Diseases

Volumn 53, Issue SUPPL. 3, 2011, Pages

  Geisler, William M ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENCE; ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; EPIDIDYMITIS; HUMAN; INFECTION PREVENTION; MALE HOMOSEXUAL; NUCLEIC ACID AMPLIFICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RECURRENT INFECTION; REVIEW; RISK FACTOR; RISK REDUCTION; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CHLAMYDIA TRACHOMATIS; DRUG MONITORING; FEMALE; HUMANS; LYMPHOGRANULOMA VENEREUM; MALE; MASS SCREENING; MOLECULAR DIAGNOSTIC TECHNIQUES; PRACTICE GUIDELINES AS TOPIC; UNITED STATES; YOUNG ADULT;

EID: 81055144401     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir698     Document Type: Review

References (46)

1. Cates W. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex Transm Dis 1999; 26:S2-7.
2. Sexually transmitted disease surveillance. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of STD Prevention, 2007.
3. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2006. MMWR Recomm Rep 2006; 55:1-94.
4. Mertz KJ, Levine WC, Mosure DJ, Berman SM, Dorian KJ, Hadgu A. Trends in the prevalence of chlamydial infections: the impact of community-wide testing. Sex Transm Dis 1997; 24:169-75. (Pubitemid 27123194)
5. Centers for Disease Control and Prevention. Chlamydia trachomatis genital infections-United States, 1995. MMWR Morb Mortal Wkly Rep 1997; 46:193-8.
6. Scholes D, Stergachis A, Heidrch FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334:1362-6. (Pubitemid 26152715)
7. Kamwendo F, Forslin L, Bodin L, Danielsson D. Decreasing incidences of gonorrhea-and chlamydia-associated acute pelvic inflammatory disease: a 25-year study from an urban area of central Sweden. Sex Transm Dis 1996; 23:384-91. (Pubitemid 26313847)
8. Schachter J, Moncada J, Liska S, Shayevich C, Klausner JD. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis 2008; 35:637-42.
9. Bachmann LH, Johnson RE, Cheng H, et al. Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections. J Clin Microbiol 2010; 48:1827-32.
10. Lister NA, Smith A, Tabrizi SN, Garland S, Fairley CK. Re-infection of Neisseria gonorrhoeae and Chlamydia trachomatis infections among men who have sex with men. Int J STD AIDS 2006; 17:415-7. (Pubitemid 43765407)
11. Kent CK, Chaw JK, Wong W, et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis 2005; 41:67-74. (Pubitemid 40863746)
12. Ivens D, Macdonald K, Bansi L, Nori A. Screening for rectal chlamydia infection in a genitourinary medicine clinic. Int J STD AIDS 2007; 18:404-6. (Pubitemid 351738983)
13. Jin F, Prestage GP, Mao L, et al. Incidence and risk factors for urethral and anal gonorrhoea and chlamydia in a cohort of HIV-negative homosexual men: the Health in Men Study. Sex Transm Infect 2007; 83:113-9. (Pubitemid 46713598)
14. Templeton DJ, Jin F, Imrie J, et al. Prevalence, incidence and risk factors for pharyngeal chlamydia in the community based Health in Men (HIM) cohort of homosexual men in Sydney, Australia. Sex Transm Infect 2008; 84:361-3.
15. Mimiaga MJ, Mayer KH, Reisner SL, et al. Asymptomatic gonorrhea and chlamydial infections detected by nucleic acid amplification tests among Boston area men who have sex with men. Sex Transm Dis 2008; 35:495-8. (Pubitemid 351670553)
16. Schachter J, Chernesky MA, Willis DE, et al. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis 2005; 32:725-8. (Pubitemid 41752557)
17. Skidmore S, Horner P, Herring A, et al. Chlamydia Screening Studies (ClaSS) Project Group. Vulvovaginal-swab or first-catch urine specimen to detect Chlamydia trachomatis in women in a community setting? J Clin Microbiol 2006; 44:4389-94. (Pubitemid 44937069)
18. Keane FE, Bendall R, Saulsbury N, Haddon L. A comparison of selftaken vulvovaginal and cervical samples for the diagnosis of Chlamydia trachomatis infection by polymerase chain reaction. Int J STD AIDS 2007; 18:98-100.
19. Hoebe CJ, Rademaker CW, Brouwers EE, ter Waarbeek HL, van Bergen JE. Acceptability of self-taken vaginal swabs and first-catch urine samples for the diagnosis of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae with an amplified DNA assay in young women attending a public health sexually transmitted disease clinic. Sex Transm Dis 2006; 33:491-5. (Pubitemid 44126892)
20. Rose SB, Lawton BA, Bromhead C, Macdonald EJ, Lund KA. Selfobtained vaginal swabs for PCR chlamydia testing: a practical alternative. Aust N Z J Obstet Gynaecol 2007; 47:415-8. (Pubitemid 47433848)
21. Doshi JS, Power J, Allen E. Acceptability of chlamydia screening using self-taken vaginal swabs. Int J STD AIDS 2008; 19:507-9.
22. Gaydos CA, Dwyer K, Barnes M, et al. Internet-based screening for Chlamydia trachomatis to reach non-clinic populations with mailed self-administered vaginal swabs. Sex Transm Dis 2006; 33:451-7. (Pubitemid 43964756)
23. Hopwood J, Mallinson H, Hodgson E, Hull L. Liquid based cytology: examination of its potential in a chlamydia screening programme. Sex Transm Infect 2004; 80:371-3. (Pubitemid 39389554)
24. Koumans EH, Black CM, Markowitz LE, et al. Comparison of methods for detection of Chlamydia trachomatis and Neisseria gonorrhoeae using commercially available nucleic acid amplification tests and a liquid pap smear medium. J Clin Microbiol 2003; 41:1507-11. (Pubitemid 36428096)
25. Chernesky M, Freund GG, Hook E 3rd, Leone P,D'Ascoli P,Martens M. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in North American women by testing SurePath liquid-based Pap specimens in APTIMA assays. J Clin Microbiol 2007; 45:2434-8. (Pubitemid 47295470)
26. Centers for Disease Control and Prevention. Male Chlamydia Screening Consultation. March 28-29, 2006. Meeting report. Available at: http://www.cdc.gov/std/chlamydia/ChlamydiaScreening-males.pdf. Accessed 27 September 2011.
27. Satterwhite CL, Joesoef MR, Datta SD, Weinstock H. Estimates of Chlamydia trachomatis infections among men: United States. Sex Transm Dis 2008; 35:S3-7.
28. Rietmeijer CA, Hopkins E, Geisler WM, Orr DP, Kent CK. Chlamydia trachomatis positivity rates among men tested in selected venues in the United States: a review of the recent literature. Sex Transm Dis 2008; 35:S8-18.
29. Gift TL, Blake DR, Gaydos CA, Marrazzo JM. The cost-effectiveness of screening men for Chlamydia trachomatis: a review of the literature. Sex Transm Dis 2008; 35:S51-60.
30. Gift TL, Gaydos CA, Kent CK, et al. The program cost and costeffectiveness of screening men for chlamydia to prevent pelvic inflammatory disease in women. Sex Transm Dis 2008; 35:S66-75.
31. Dunne EF, Chapin JB, Rietmeijer CA, et al. Rate and predictors of repeat Chlamydia trachomatis infection among men. Sex Transm Dis 2008; 35:S40-4.
32. Newman LM, Warner L, Weinstock HS. Predicting subsequent infection in patients attending sexually transmitted disease clinics. Sex Transm Dis 2006; 33:737-42. (Pubitemid 44832934)
33. Lee VF, Tobin JM, Harindra V. Re-infection of Chlamydia trachomatis in patients presenting to the genitourinary medicine clinic in Portsmouth: the chlamydia screening pilot study-three years on. Int J STD AIDS 2004; 15:744-6. (Pubitemid 39540701)
34. Fung M, Scott KC, Kent CK, Klausner JD. Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting. Sex Transm Infect 2007; 83:304-9. (Pubitemid 47242509)
35. Hu D, Hook EW 3rd, Goldie SJ. The impact of natural history parameters on the cost-effectiveness of Chlamydia trachomatis screening strategies. Sex Transm Dis 2006; 33:428-36. (Pubitemid 43964752)
36. Geisler WM, Wang C, Morrison SG, Black CM, Bandea CI, Hook EW 3rd. The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment. Sex Transm Dis 2008; 35:119-23. (Pubitemid 351158688)
37. Joyner JL, Douglas JM Jr, Foster M, Judson FN. Persistence of Chlamydia trachomatis infection detected by polymerase chain reaction in untreated patients. Sex Transm Dis 2002; 29:196-200. (Pubitemid 34275207)
38. Parks KS, Dixon PB, Richey CM, Hook EW 3rd. Spontaneous clearance of Chlamydia trachomatis infection in untreated patients. Sex Transm Dis 1997; 24:229-35. (Pubitemid 27155105)
39. Rogers SM, Miller WC, Turner CF, et al. Concordance of Chlamydia trachomatis infections within sexual partnerships. Sex Transm Infect 2008; 84:23-8. (Pubitemid 351195846)
40. Sheffield JS, Andrews WW, Klebanoff MA, et al. Spontaneous resolution of asymptomatic Chlamydia trachomatis in pregnancy. Obstet Gynecol 2005; 105:557-62. (Pubitemid 40271222)
41. van den Brule AJ, Munk C, Winther JF, et al. Prevalence and persistence of asymptomatic Chlamydia trachomatis infections in urine specimens from Danish male military recruits. Int J STD AIDS 2002; 13:S19-22.
42. van Valkengoed IG, Morré SA, van den Brule AJ, et al. Follow-up, treatment, and reinfection rates among asymptomatic Chlamydia trachomatis cases in general practice. Br J Gen Pract 2002; 52:623-7.
43. Molano M, Meijer CJ, Weiderpass E, et al. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. J Infect Dis 2005; 191:907-16. (Pubitemid 40349806)
44. Morré SA, van den Brule AJ, Rozendaal L, et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up. Int J STD AIDS 2002; 13:S12-8.
45. Bachmann LH, Richey CM, Waites K, et al. Patterns of Chlamydia trachomatis testing and follow-up at a university hospital medical center. Sex Transm Dis 1999; 26:496-9. (Pubitemid 29485338)
46. Hook EW 3rd, Spitters C, Reichart CA, et al. Use of cell culture and a rapid diagnostic assay for Chlamydia trachomatis screening. JAMA 1994; 272:867-70. (Pubitemid 24282096)